新型隐球菌脑膜炎 - 参考文献
参考文献
病因
[1] | Casadevall A, Perfect JR. Cryptococcus neoforman [M]. Washington DC: ASM Press. 1998,41-70. |
病理解剖
[1] | 王维治. 神经病学. 第1版. 676-677. |
病理生理
[1] | Baker RD. The primary pulmonary lymph node complex of cryptococcosis. Am J Clin Pathol.1976;65:83-92. |
pubmed摘要 |
[2] | Chrerien F, Lortholary O, Kansau I, et al. Pathogenesis of cerebral Cryptococcus neoformanns infection after fungemia. J Infect Dis. 2002;186(4):522-530。 |
pubmed摘要 |
[3] | Bose I,Reese AJ,Ory JJ,Janbon G,Doering TL. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell. 2003 Aug. 2(4): 655-63. |
pubmed摘要 | 全文链接 |
[4] | Cox GM,McDade HC,Chen SC,Tucker SC,Gottfredsson M,Wright LC,Sorrell TC,Leidich SD,Casadevall A,Ghannoum MA,Perfect JR. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol. 2001 Jan. 39(1): 166-75. |
pubmed摘要 |
[5] | D'Souza CA,Alspaugh JA,Yue C,Harashima T,Cox GM,Perfect JR,Heitman J. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol. 2001 May. 21(9): 3179-91. |
pubmed摘要 | 全文链接 |
[6] | Ambrose YJ,Wu CH, J iang S, et al. HIV21 gp41 ectodomain enhances. Cryptococcus neoform ans binding to HBMEC biochemical and biophysical. Research Communications. 2007;356(3):8992905. |
诊断标准
[1] | 王维治. 神经病学. 2006年第1版,677. |
治疗细则
[1] | Saag MS,Graybill RJ,Larsen RA,Pappas PG,Perfect JR,Powderly WG,Sobel JD,Dismukes WE. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000 Apr. 30(4): 710-8. |
pubmed摘要 | PDF全文 |
[2] | Macsween K, Bicanic T, Brouwenr AE, et al. Harrison TS. Lumbar drainage in control of cerebrospinal fluid pressure in cryptococcal meningitis: Case report and review. J Infect. 2005,inpress. |
pubmed摘要 |
[3] | Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococal meningitis by use of shunting. Clin Infect Dis. 1999;28:629-633. |
pubmed摘要 |
[4] | Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious disease society of America. Clin Infect Dis. 2010;50(3):291-322. |
pubmed摘要 |
[5] | Casadevall A, Cleare W, Feldmesser M . Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother. 1998;42:1437-46. |
pubmed摘要 | 全文链接 | PDF全文 |
[6] | Pappas PG,Bustamante B,Ticona E,Hamill RJ,Johnson PC,Reboli A,Aberg J,Hasbun R,Hsu HH. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis. 2004 Jun 15. 189(12): 2185-91. |
pubmed摘要 | PDF全文 |
[7] | Woods ML 2nd,MacGinley R,Eisen DP,Allworth AM. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS. 1998 Aug 20. 12(12): 1491-4. |
pubmed摘要 |
预后
[1] | Dismukes WE,Cloud G,Gallis HA,Kerkering TM,Medoff G,Craven PC,Kaplowitz LG,Fisher JF,Gregg CR,Bowles CA. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987 Aug 6. 317(6): 334-41. |
pubmed摘要 |
[2] | Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med.1974;80:176-181. |
pubmed摘要 |
[3] | Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet.2004;363:1764-1767. |
pubmed摘要 |
[4] | Mirza SA, Phelan M, Rimland D. The changing epidemiology of |
pubmed摘要 |
[5] | Imwidthaya P, Poungvarin N. Cryptococcosis in AIDS. Postgrad Med J.2000;76:85-88. |
pubmed摘要 |
[6] | Larsen RA, Bauer M, Thomas AM, et al.Amphotericin B and fluconazole, a |
pubmed摘要 | 全文链接 | PDF全文 |
[7] | White M, Cirrincione C, Blevins A, et al. Cryptococcal meningitis with AIDS and patients with neoplastic disease. J Infect Dis. 1992;165:960-6. |
pubmed摘要 |
[8] | Husain A, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis.2001;7:375-81. |
pubmed摘要 |
[9] | Seaton RA, Naraqi S, Wembri JP, et al. Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. Q J Med.1996;89:423-8. |
pubmed摘要 |